Jesse Papenburg

6.0k total citations
113 papers, 2.3k citations indexed

About

Jesse Papenburg is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jesse Papenburg has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Epidemiology, 48 papers in Infectious Diseases and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jesse Papenburg's work include Respiratory viral infections research (63 papers), Influenza Virus Research Studies (31 papers) and Pneumonia and Respiratory Infections (21 papers). Jesse Papenburg is often cited by papers focused on Respiratory viral infections research (63 papers), Influenza Virus Research Studies (31 papers) and Pneumonia and Respiratory Infections (21 papers). Jesse Papenburg collaborates with scholars based in Canada, United States and Mongolia. Jesse Papenburg's co-authors include Guy Boivin, Caroline Quach, Matthew P. Cheng, Cédric P. Yansouni, Caroline Chartrand, Michael Libman, Sanjat Kanjilal, Michaël Desjardins, Sabine Dittrich and Chelsea Caya and has published in prestigious journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jesse Papenburg

97 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse Papenburg Canada 22 1.3k 1.1k 376 201 195 113 2.3k
René Gottschalk Germany 24 642 0.5× 1.1k 1.0× 285 0.8× 215 1.1× 61 0.3× 94 2.2k
Matthew P. Cheng Canada 25 826 0.6× 1.4k 1.3× 152 0.4× 154 0.8× 160 0.8× 113 2.6k
Yae‐Jean Kim South Korea 26 875 0.7× 1.6k 1.5× 336 0.9× 462 2.3× 83 0.4× 151 3.0k
Faiz Ahmad Khan Canada 20 666 0.5× 1.4k 1.4× 276 0.7× 535 2.7× 172 0.9× 57 2.2k
Pieter L. A. Fraaij Netherlands 24 1.2k 0.9× 921 0.9× 368 1.0× 67 0.3× 63 0.3× 74 2.3k
Frank Esper United States 20 1.1k 0.9× 1.3k 1.2× 385 1.0× 341 1.7× 69 0.4× 39 2.0k
Benoît Visseaux France 24 685 0.5× 1.3k 1.2× 151 0.4× 75 0.4× 141 0.7× 122 1.9k
Andrea Orsi Italy 25 1.5k 1.1× 721 0.7× 110 0.3× 93 0.5× 58 0.3× 131 2.2k
Jin Xu China 22 367 0.3× 1.1k 1.0× 130 0.3× 144 0.7× 159 0.8× 61 1.7k
Antonia Ho United Kingdom 13 473 0.4× 1.2k 1.1× 158 0.4× 52 0.3× 165 0.8× 29 1.9k

Countries citing papers authored by Jesse Papenburg

Since Specialization
Citations

This map shows the geographic impact of Jesse Papenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Papenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Papenburg more than expected).

Fields of papers citing papers by Jesse Papenburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Papenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Papenburg. The network helps show where Jesse Papenburg may publish in the future.

Co-authorship network of co-authors of Jesse Papenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Papenburg. A scholar is included among the top collaborators of Jesse Papenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Papenburg. Jesse Papenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawandi, Alexander, Chelsea Caya, Todd C. Lee, et al.. (2025). Antibiotic synergy against Staphylococcus aureus : a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. 69(8). e0119924–e0119924.
2.
Top, Karina A., Julie A. Bettinger, Joanne E. Embree, et al.. (2025). Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study. The Journal of Pediatrics. 284. 114642–114642. 1 indexed citations
3.
Papenburg, Jesse, et al.. (2024). Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy. Canada Communicable Disease Report. 50(3/4). 86–92. 2 indexed citations
4.
Papenburg, Jesse, et al.. (2024). The Critical Lens: It is time to start using the right test for febrile young infants. Paediatrics & Child Health. 29(7). 419–421. 1 indexed citations
5.
Ouldali, Naïm, Marc Lebel, Rodica Gilca, et al.. (2024). Use of the moving epidemic method to guide the launch of palivizumab immunization campaigns for respiratory syncytial virus in Québec, Canada. Canadian Journal of Public Health. 116(5). 748–756. 1 indexed citations
6.
Mahshid, Sara, Tamer AbdElFatah, Dao Nguyen, et al.. (2024). Next-generation rapid phenotypic antimicrobial susceptibility testing. Nature Communications. 15(1). 9719–9719. 16 indexed citations
7.
Wong, Kimberly, et al.. (2023). 44 Ceftriaxone Prescribing Patterns in an Outpatient Hospital Setting: A Quality Improvement Study. Paediatrics & Child Health. 28(Supplement_1). e19–e20.
8.
Zinszer, Kate, Katia Charland, Marie‐Ève Hamelin, et al.. (2023). Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada. Influenza and Other Respiratory Viruses. 17(8). e13186–e13186. 4 indexed citations
9.
Caya, Chelsea, Matthew P. Cheng, Karen Colwill, et al.. (2023). Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept. Vox Sanguinis. 118(12). 1069–1077. 2 indexed citations
10.
Zinszer, Kate, Katia Charland, Marie‐Ève Hamelin, et al.. (2023). Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada. International Journal of Infectious Diseases. 131. 119–126. 4 indexed citations
11.
Morris, Shaun K., Julie A. Bettinger, Christina Bancej, et al.. (2023). Bloodstream Infections in Children Hospitalized for Influenza, the Canadian Immunization Monitoring Program Active. The Pediatric Infectious Disease Journal. 43(4). 301–306. 2 indexed citations
12.
Schober, Tilmann, Shaun K. Morris, Julie A. Bettinger, et al.. (2023). Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT). Clinical Microbiology and Infection. 29(7). 924–932. 4 indexed citations
13.
Robinson, Joan, Chelsea Caya, Justina Marianayagam, et al.. (2022). Urgent air transfers for acute respiratory infections among children from Northern Canada, 2005–2014. PLoS ONE. 17(7). e0272154–e0272154. 1 indexed citations
14.
Papenburg, Jesse, et al.. (2022). Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022–2023. Canada Communicable Disease Report. 48(9). 373–382. 4 indexed citations
15.
Papenburg, Jesse, Matthew P. Cheng, Rachel Corsini, et al.. (2021). Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay. Open Forum Infectious Diseases. 8(6). ofab220–ofab220. 27 indexed citations
16.
Kazzaz, Yasser, Caroline Quach, Douglas F. Willson, et al.. (2021). Evaluation of antibiotic treatment decisions in pediatric intensive care units in Saudi Arabia: A national survey. Journal of Infection and Public Health. 14(9). 1254–1262.
17.
Gilca, Rodica, Marie‐Noëlle Billard, Jesse Papenburg, et al.. (2020). Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada. Preventive Medicine Reports. 20. 101180–101180. 7 indexed citations
18.
Cheng, Matthew P., Cédric P. Yansouni, Nicole E. Basta, et al.. (2020). Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2. Annals of Internal Medicine. 173(6). 450–460. 91 indexed citations
19.
Alghounaim, Mohammad, Chelsea Caya, Marc Beltempo, et al.. (2020). Impact of decreasing cerebrospinal fluid enterovirus PCR turnaround time on costs and management of children with suspected enterovirus meningitis. European Journal of Clinical Microbiology & Infectious Diseases. 39(5). 945–954.
20.
Baz, Mariana, Jesse Papenburg, Marie‐Ève Hamelin, et al.. (2012). Seroconversion to Seasonal Influenza Viruses after A(H1N1)pdm09 Virus Infection, Quebec, Canada. Emerging infectious diseases. 18(7). 1132–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026